CURES 2.0 Leading Women's Health Forward

CURES 2.0

Leading Women's Health Forward

Virtual Policy Discussion

Programs

HealthyWomen’s goal of the briefing is to educate Congressional staff, HealthyWomen’s Corporate Advisory Council, federal agencies and all stakeholders in women’s health about the provisions related to patient access, caregiver resources and supports, telehealth advancement, and next steps Congress should take.

Cures 2.0 is a broad federal bill led by Representatives Diana DeGette (D-CO) and Fred Upton (R-MI). The first iteration of this bill was passed in 2016 as the 21st Century Cures Act. By the end of 2022, many of the programs that were created back in 2016 will have to be reauthorized to maintain their funding. Cures 2.0 would not only serve as the legislative vehicle to reauthorize those important programs but build on their successes as well.

Watch the video of the presentation

View the presentation in PDF format here.

Experts discuss how CURES 2.0 impacts women's health care.

Thank you to our Corporate Advisory Council member organizations — Alora, Astellas, Covis Pharma, Eli Lilly, Hologic, Myovant Sciences, Novo Nordisk, Pfizer and Viatris.

Speakers

Arika Pierce, J.D.

Arika Pierce, J.D., Piercing Strategies, CEO and Founder, Moderator

Fawn Cothran, Ph.D., RN, GCNS-BC, FGSA

Fawn Cothran, Ph.D., RN, GCNS-BC, FGSA, Hunt Research Director, National Alliance for Caregiving

Jeannine M. Brant, Ph.D., APRN-CNS, AOCN, FAAN

Jeannine M. Brant, Ph.D., APRN-CNS, AOCN, FAAN, President, Oncology Nursing Society

Nisha Quasba

Nisha Quasba, Advisor, Faegre Drinker

Ashira Vantrees, J.D.

Ashira Vantrees, J.D., Staff Attorney, Aimed Alliance

HealthyWomen’s goal of the briefing is to educate Congressional staff, HealthyWomen’s Corporate Advisory Council, federal agencies and all stakeholders in women’s health about the provisions related to patient access, caregiver resources and supports, telehealth advancement, and next steps Congress should take.

Cures 2.0 is a broad federal bill led by Representatives Diana DeGette (D-CO) and Fred Upton (R-MI). The first iteration of this bill was passed in 2016 as the 21st Century Cures Act. By the end of 2022, many of the programs that were created back in 2016 will have to be reauthorized to maintain their funding. Cures 2.0 would not only serve as the legislative vehicle to reauthorize those important programs but build on their successes as well.

Watch the video of the presentation

View the presentation in PDF format here.

Experts discuss how CURES 2.0 impacts women's health care.

Thank you to our Corporate Advisory Council member organizations — Alora, Astellas, Covis Pharma, Eli Lilly, Hologic, Myovant Sciences, Novo Nordisk, Pfizer and Viatris.

Speakers

Arika Pierce, J.D.

Arika Pierce, J.D., Piercing Strategies, CEO and Founder, Moderator

Fawn Cothran, Ph.D., RN, GCNS-BC, FGSA

Fawn Cothran, Ph.D., RN, GCNS-BC, FGSA, Hunt Research Director, National Alliance for Caregiving

Jeannine M. Brant, Ph.D., APRN-CNS, AOCN, FAAN

Jeannine M. Brant, Ph.D., APRN-CNS, AOCN, FAAN, President, Oncology Nursing Society

Nisha Quasba

Nisha Quasba, Advisor, Faegre Drinker

Ashira Vantrees, J.D.

Ashira Vantrees, J.D., Staff Attorney, Aimed Alliance

ADVERTISEMENT